News Focus
News Focus
icon url

TastyTheElf

04/25/20 7:25 PM

#269160 RE: studythosestocks #269155

Great post studythosestocks. Honest and raw.

“If you’re going through hell, keep going.” -- Winston Churchill
icon url

cruyff22

04/25/20 7:59 PM

#269168 RE: studythosestocks #269155

Great Post Study , agree completely, ALLIN.
icon url

postes

04/25/20 8:00 PM

#269169 RE: studythosestocks #269155

Study...inspirational....thank you
icon url

Biobillionair

04/25/20 8:01 PM

#269170 RE: studythosestocks #269155

Study-

With 2 very favorable judges then our odds may come around to 60-65% IMO and we won’t know that until the day of oral arguments.



Your email to JT is further enabling management agenda of ‘how can I get really rich‘. These asses had an opportunity to settle with both Hikma and Ready...they flat out refused! Can I prove they refused? Absolutely....no deal was made! Management could have offered an earlier entry into R-I as bait....they failed...or refused...either way incompetence is the only defining word that accurately describes the lack of settlement.

Management had a bonus scheduled to include protection of IP...? Unclear at this moment, but that’s something I want answered!

I love Vascepa but hate Amarin! Management is absolutely incompetent and that includes JT letting Kennedy drive “strategy”; only mistake after mistake following refusal to litigate ACHOR SPA rescindment. AMARIN was ONLY toting big pharmaceutical First Amendment agenda!!! Only reasons why they didn’t protect AMRN longs, sucking up to BP agenda and attempting to enrich themselves in a clean IP win!

Mistake after mistake...an appeal win odds is less than 25%! Facts are diluted by Judge Du decision and her appeal record of less than 10% reversal.

Consider sending JT a second email.

BB

icon url

bfost

04/25/20 9:01 PM

#269178 RE: studythosestocks #269155

Study - You expressed well what most of us felt that day. I put it out of my mind quickly when it resurfaces - but the sting is still there.

We all understand it's still an uphill battle - but most have decided the battle is what we want - maybe naive - we'll see.

Loved the game link! Great to see sports again - Forgot about that amazing comeback.

Thanks
icon url

Whalatane

04/25/20 9:21 PM

#269182 RE: studythosestocks #269155

Study. Haven’t read the whole thing but 2 quick questions

Was AMRN the only stock you owned at the time ?

If you owned other stocks ... what % of your portfolio was AMRN ?

Thx. Kiwi
icon url

Markipeach

04/25/20 10:00 PM

#269197 RE: studythosestocks #269155

Think again- consider another letter more realistic- youre living in a dream world
icon url

MNBioMike

04/25/20 10:12 PM

#269206 RE: studythosestocks #269155

Great post. Only thing I disagree on is partnering in EU. They either win appeal and sell whole thing or lose appeal and sell Europe. Partnering is a ploy.

Thanks for sharing and hang in there. EU is worth $15, minimum.
icon url

circuitcity

04/26/20 12:13 AM

#269218 RE: studythosestocks #269155

Thank you for sharing, took a lot of courage, for what is worth, you are not alone. To show my respect to you, I won’t say anything bad here about mgmt, but really, that SOB didn’t reply to you at all?
icon url

venus537

04/26/20 3:51 AM

#269237 RE: studythosestocks #269155

STS-

Although I appreciate your heartfelt post I don't want to go down with the ship. If an equitable deal can be made for Europe or a not so equitable deal for Europe but with a CVR for the U.S. market then swallow your pride and accept it. Negotiating a deal holding the bag after an appeal loss would be like swimming in shark infested waters.

Publicly Amarin's plan is then to compete with the generics with their own generic Vascepa in the U.S. and have partnerships in Europe. That sounds like a nightmare within a nightmare.